ArticleVaccine2025
Prediction of subnational-level vaccination coverage estimates using routine surveillance data and survey data.
Article in Vaccine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Interpreting Breakthrough Infections Given Assortative Mixing of Partially Vaccinated Populations.medRxiv : the preprint server for health sciences · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
backgroundMeasles vaccination has significantly reduced the global burden of the disease, but disparities in vaccination coverage persist. Accurate and timely estimates of subnational vaccination coverage are crucial for identifying high-risk areas and guiding targeted interventions. However, existing methods face limitations related to accuracy, timeliness, and spatial resolution. We explored the use of routinely collected case-based surveillance data to predict measles vaccination coverage at the subnational level.
methodsThe study used aggregated case data from 18 countries in the WHO African region, obtained from the WHO measles surveillance database. Three surveillance-based indicators were derived: mean age of suspected measles cases, proportion of vaccinated suspected cases, and proportion of IgM-negative suspected cases. These indicators were used to build a beta regression model with measles vaccination coverage from the Demographic and Health Surveys (DHS) as the gold standard. We compared out-of-sample predictions created using this model to withheld DHS estimates using Pearson's rho.
findingsWe found that each of the three surveillance-based indicators were more strongly correlated with DHS-based survey coverage than administrative estimates. Out-of-sample predictions achieved high correlation with DHS-based coverage, with a rho of 0.74.
interpretationThe findings suggest that routinely collected measles surveillance data can effectively predict subnational measles vaccination coverage. The approach addresses limitations of existing methods by providing yearly estimates that are more accurate than administrative data and more readily available than surveys. This enables timely identification of low-coverage areas and facilitates targeted interventions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.